Lyora Therapeutics, Inc.
BiotechnologyBiotechnology
Belmont, MA
2024
founded
About
Lyra Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to developing groundbreaking therapies specifically for chronic rhinosinusitis (CRS), a prevalent inflammatory condition affecting the nasal passages and sinuses. By leveraging innovative technologies, Lyra aims to provide effective solutions for CRS patients who often endure ineffective treatments and potentially invasive surgeries.
Company Values
Lyra stands out through its proprietary XTreo technology platform, which enables sustained, localized medication delivery to ENT tissues without the need for invasive procedures.